Singapore based Proteona has announced that US headquartered Twist Bioscience will join the international alliance led by Proteona to develop neutralizing antibody therapy against COVID-19 for vulnerable immunocompromised patients.
PixVC provides early-stage venture capital to startups in the areas of Info-Tech, Med-Tech and Eco-Tech.